Hyperfine (HYPR) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Hyperfine Revenue Highlights


Latest Revenue (Y)

$11.03M

Latest Revenue (Q)

$3.63M

Main Geography (Y)

Non-US

Hyperfine Revenue by Period


Hyperfine Revenue by Year

DateRevenueChange
2023-12-31$11.03M61.90%
2022-12-31$6.81M355.48%
2021-12-31$1.50M408.84%
2020-12-31$294.00K100.00%
2019-12-31--

Hyperfine generated $11.03M in revenue during NA 2023, up 61.90% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Hyperfine Revenue by Quarter

DateRevenueChange
2024-06-30$3.63M10.20%
2024-03-31$3.29M22.67%
2023-12-31$2.69M15.28%
2023-09-30$2.33M-31.09%
2023-06-30$3.38M28.31%
2023-03-31$2.63M85.04%
2022-12-31$1.42M-39.35%
2022-09-30$2.35M53.16%
2022-06-30$1.53M1.59%
2022-03-31$1.51M246.10%
2021-12-31$436.00K17.52%
2021-09-30$371.00K3.63%
2021-06-30$358.00K8.16%
2021-03-31$331.00K59.90%
2020-12-31$207.00K459.46%
2020-09-30$37.00K48.00%
2020-06-30$25.00K-
2020-03-31$25.00K-

Hyperfine generated $3.63M in revenue during Q2 2024, up 10.20% compared to the previous quarter, and up 137.80% compared to the same period a year ago.

Hyperfine Revenue Breakdown


Hyperfine Revenue Breakdown by Product

Quarterly Revenue by Product

Product/ServiceMar 24Sep 23Jun 23Mar 23
Service$591.00K$602.00K$114.00K-
Product$2.70M$1.73M$2.81M-

Hyperfine's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Product (82.06%), and Service (17.94%).

Hyperfine Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Dec 21
Non-US$4.36M$2.54M-
AUSTRALIA--$78.00K

Hyperfine's latest annual revenue breakdown by geography, as of Dec 23: Non-US (100.00%).

Quarterly Revenue by Country

CountryMar 24Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22
Non-US Countries$2.43M$65.00K$2.90M$1.03M$784.00K$561.00K--
Service---$114.00K----
Non-US----$591.00K---
Canada and Pakistan-------$509.00K

Hyperfine's latest quarterly revenue breakdown by geography, as of Mar 24: Non-US Countries (100.00%).

Hyperfine Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
PAVMPAVmed$2.45B$979.00M
ITGRInteger$1.60B$753.01M
LIVNLivaNova$1.15B$318.60M
INGNInogen$315.66M$88.77M
ANIKAnika Therapeutics$166.66M$41.92M
KIDSOrthoPediatrics$148.73M$52.80M
SRDXSurmodics$132.58M$30.34M
LUNGPulmonx$68.67M$20.78M
IRMDIRadimed$65.56M$17.93M
NPCENeuroPace$65.42M$18.12M
APYXApyx Medical$52.35M$12.15M
OSAProSomnus$27.65M$7.46M
HYPRHyperfine$11.03M$3.63M
OFIXOrthofix Medical$100.00K$198.62M

HYPR Revenue FAQ


Hyperfine's yearly revenue for 2023 was $11.03M, representing an increase of 61.90% compared to 2022. The company's yearly revenue for 2022 was $6.81M, representing an increase of 355.48% compared to 2021. HYPR's yearly revenue for 2021 was $1.5M, representing an increase of 408.84% compared to 2020.

Hyperfine's quarterly revenue for Q2 2024 was $3.63M, a 10.20% increase from the previous quarter (Q1 2024), and a 7.39% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $3.3M, a 22.67% increase from the previous quarter (Q4 2023), and a 25.05% increase year-over-year (Q1 2023). HYPR's quarterly revenue for Q4 2023 was $2.69M, a 15.28% increase from the previous quarter (Q3 2023), and a 88.62% increase year-over-year (Q4 2022).

Hyperfine's revenue growth rate for the last 3 years (2021-2023) was 637.43%, and for the last 5 years (2019-2023) was 0%.